Dr. Schneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
345 23rd Ave N
Ste 201
Nashville, TN 37203Phone+1 615-983-6000Fax+1 615-983-6010
Summary
- Dr. Eric Schneider is an ophthalmologist in Nashville, TN. He received his medical degree from University of Michigan Medical School and has been in practice 9 years. He is experienced in general / comprehensive ophthalmology and vitreoretinal disease.
Education & Training
- University of Michigan Health SystemResidency, Ophthalmology, 2009 - 2012
- Corewell Health East Beaumont (Dearborn & Taylor)Internship, Transitional Year, 2008 - 2009
- University of Michigan Medical SchoolClass of 2008
Certifications & Licensure
- KY State Medical License 2014 - 2025
- TN State Medical License 2014 - 2025
- NC State Medical License 2012 - 2015
- MI State Medical License 2008 - 2012
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) Start of enrollment: 2017 Apr 01
Publications & Presentations
PubMed
- Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration.Jeffrey S Heier, Yingna Liu, Nancy M Holekamp, Mohsin H Ali, Konstantin Astafurov
Journal of Vitreoretinal Diseases. 2024-12-07 - Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1.Jessica M Girgis, Caroline R Baumal, Andre J Witkin, Lejla Vajzovic, Roger A Goldberg
Journal of Vitreoretinal Diseases. 2024-08-22 - 2 citationsHome Optical Coherence Tomography Monitoring for Neovascular Age-Related Macular Degeneration: Transformative Technology or Cool Toy?Ethan T Willis, Judy E Kim, Eric W Schneider
Ophthalmology and Therapy. 2024-06-01
Press Mentions
- Anti-VEGF Targeted as Potential nAMD TreatmentNovember 8th, 2019
- NEW PRODUCT APPLICATIONS: Streamlining the Image Review ProcessJuly 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: